August 30th, 2021- Simcere Pharmaceutical Group Co., Ltd. (2096.HK, hereinafter referred to as "Simcere") and AlphaMa Biotechnology Co., Ltd. (hereinafter referred to as "AlphaMa") jointly announced that they have successfully signed an exclusive license agreement for the new anti-tumor drug ALM005 . According to the agreement, Simcere Pharmaceuticals will obtain the rights to develop all indications of ALM005 and commercialize…
2021/09/01
AlphaMa Biotech (“AlphaMa”) is pleased to announce that the company has entered into a research collaboration with Eli Lilly and Company (“Lilly”) to utilize AlphaMa’s proprietary intelligent DNA-encoded libraries (“iDEL”) for drug discovery and development in selected therapeutic areas. AlphaMa has established a unique platform that integrates DNA-encoded library (DEL) and Artificial Intelligence (AI) for small molecule drug discovery. With…
2021/07/24
After three months of fierce competition, the Bristol-Myers Squibb-Molecular Translation Competition organized by Kaggle, a well-known data science competition platform, ended at 8 a.m. Beijing time on June 4th. The competition attracted nearly a thousand data scientists from all over the world. The final winner, called SIMM DDDC, is a joint team composed of Dr. Xiaohong Liu from AlphaMa Biotechnology…
2021/06/10
On January 27, Suzhou AlphaMa Biotechnology Co., Ltd. (hereinafter referred to as "AlphaMa") ??and Suzhou Institute of Drug Innovation Shanghai Institute of Materia Medica (hereinafter referred to as "SUSIMM") signed a strategic alliance agreement with Hefei KS-V Peptide. AlphaMa and KS-V Peptide's representatives signed the "DEL Technology-based Artificial Intelligence Boosted Drug Screening Collaborative Agreement" on the afternoon of January 27.…
2021/01/29
AlphaMa will cooperate with Viva Biotech to provide clients AI-based DNA Encoded compound library screening technology. SHANGHAI, CHINA----Recently, AlphaMa Biotech signed a new drug discovery technology cooperation agreement with Viva Biotech Co., Ltd. (hereinafter referred to as " Viva"). According to the agreement, AlphaMa will cooperate with Viva Biotech on innovative drug discovery technology to provide clients with the new…
2020/12/21
Simcere Pharmaceuticals and AlphaMa Biotech signed an exclusive license agreement for the new anti-tumor drug ALM005
AlphaMa and Lilly Collaborate on Drug Discovery Based on Intelligent DNA-Encoded Libraries
AlphaMa & SIMM Joint Team Won the Champion of the International Molecular Translation Challenge
New Year’s Big Move! Biotech Pioneers Teamed Up for In-depth Cooperation! ——AlphaMa and KS-V Peptide Signed a Strategic Alliance Agreement
AlphaMa and Viva Biotech Reached Cooperation Agreement on IntelligentDEL (iDEL) Screening Platform
